Published Aug 12, 2026
Acurx Q1 FY2026: A First-in-Class Antibiotic Priced Below the Cash It Holds
In-depth research on ACXP covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.
3,243 words14 min read
Read report